Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10347243 | 0.87 | TSHR (0.40) | TSHR | |
| SCHEMBL42248 | 0.84 | — | — | |
| SCHEMBL10611346 | 0.83 | DNM1 (0.36) | TSHR | |
| SCHEMBL10347443 | 0.79 | OPRM1 (0.42) | TSHR | |
| SCHEMBL3884688 | 0.79 | — | — | |
| SCHEMBL1447644 | 0.77 | LMNA (0.48) | — | |
| SCHEMBL7010805 | 0.77 | — | — | |
| SCHEMBL28617833 | 0.74 | LMNA (0.32) | TSHR | |
| SCHEMBL4134630 | 0.74 | — | — | |
| Ethylene SCHEMBL28232721 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4265595-A1 | SULFONATE COMPOSITION PRODUCTION METHOD | Kao Corporation (JP) | 2023-10-25 | — | — | EP | claimed |
| EP-4265596-A1 | SULFONATE COMPOSITION | Kao Corporation (JP) | 2023-10-25 | — | — | EP | claimed |
| US-20230331666-A1 | METHOD FOR PRODUCING SULFONATE COMPOSITION | KAO CORPORATION (JP) | 2023-10-19 | — | — | US | claimed |
| CN-116568670-A | Method for producing sulfonate composition | 花王株式会社 | 2023-08-08 | — | — | CN | claimed |
| CN-116406354-A | Sulfonate composition | 花王株式会社 | 2023-07-07 | — | — | CN | claimed |
| CN-103068786-B | Cosmetic preparation | COGNIS IP MANAGEMENT GMBH (DE) | 2016-01-20 | — | — | CN | claimed |
| US-8940943-B2 | Cosmetic preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2015-01-27 | — | — | US | claimed |
| EP-2601166-A1 | COSMETIC PREPARATIONS | Cognis IP Management GmbH (DE) | 2013-06-12 | — | — | EP | claimed |
| US-20130131188-A1 | Cosmetic Preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2013-05-23 | — | — | US | claimed |
| CN-103068786-A | Cosmetic preparation | COGNIS IP MAN GMBH | 2013-04-24 | — | — | CN | claimed |
| EP-2426101-A1 | Cosmetic preparations | Cognis IP Management GmbH (DE) | 2012-03-07 | — | — | EP | claimed |
| WO-2012016642-A1 | COSMETIC PREPARATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2012-02-09 | — | — | WO | claimed |
| EP-4365287-A1 | METHOD FOR PROMOTING ENZYMATIC REACTION | Kao Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117377758-A | Enzymatic reaction promotion method | 花王株式会社 | 2024-01-09 | — | — | CN | disclosed |
| EP-4265595-A1 | SULFONATE COMPOSITION PRODUCTION METHOD | Kao Corporation (JP) | 2023-10-25 | — | — | EP | disclosed |
| EP-4265596-A1 | SULFONATE COMPOSITION | Kao Corporation (JP) | 2023-10-25 | — | — | EP | disclosed |
| EP-2268764-A1 | USE OF TENSIDE MIXTURES FOR TERTIARY OIL PRODUCTION | BASF SE (DE) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009130141-A1 | USE OF TENSIDE MIXTURES FOR TERTIARY OIL PRODUCTION | BASF SE (DE) | 2009-10-29 | — | — | WO | disclosed |
| US-20090270281-A1 | USE OF SURFACTANT MIXTURES FOR TERTIARY MINERAL OIL EXTRACTION | BASF SE (DE) | 2009-10-29 | — | — | US | disclosed |
| EP-1591466-A1 | Preparation of a polyether composition | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131188-A1 | Cosmetic Preparations | CYP1B1, CBR1, ACOX3 | TSHR 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.